当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析

联环药业

(600513)

  

流通市值:27.92亿  总市值:27.92亿
流通股本:2.85亿   总股本:2.85亿

联环药业(600513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.08亿元,每股收益0.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益157818.78万元,未分配利润76214.53万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产303058.65万元,负债145239.87万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,644,578,576.251,126,339,878.99528,459,397.272,174,100,305.52
营业总成本1,516,612,393.881,035,476,886.36481,823,038.522,016,158,761.63
营业利润122,482,789.5487,252,305.6346,683,061.07174,771,965.14
利润总额121,979,496.6587,068,562.6746,578,061.07175,032,056.82
净利润107,539,004.5972,681,079.5936,998,598.44151,340,323.71
其他综合收益-73,049.96-43,210.19-81,359.12-195,308.71
综合收益总额107,465,954.6372,637,869.436,917,239.32151,145,015
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,384,873,898.481,336,824,219.561,302,483,966.21,353,403,011.17
非流动资产合计1,645,712,564.311,590,577,903.841,527,488,942.721,502,299,302.6
资产总计3,030,586,462.792,927,402,123.42,829,972,908.922,855,702,313.77
流动负债合计1,431,127,265.441,356,866,880.461,184,030,721.221,246,521,384.6
非流动负债合计21,271,419.9227,175,550.7491,714,685.0891,870,665.87
负债合计1,452,398,685.361,384,042,431.21,275,745,406.31,338,392,050.47
归属于母公司股东权益合计1,403,996,744.381,374,215,324.681,386,653,076.781,354,189,077.5
股东权益合计1,578,187,777.431,543,359,692.21,554,227,502.621,517,310,263.3
负债和股东权益合计3,030,586,462.792,927,402,123.42,829,972,908.922,855,702,313.77
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,816,743,541.61,282,702,295.84604,224,820.252,356,201,227.32
经营活动现金流出小计1,792,699,438.631,310,160,134.66622,108,376.052,195,499,431.83
经营活动产生的现金流量净额24,044,102.97-27,457,838.82-17,883,555.8160,701,795.49
投资活动现金流入小计700--28,479,115.68
投资活动现金流出小计135,919,447.42116,044,532.6934,576,429.51213,172,997.31
投资活动产生的现金流量净额-135,918,747.42-116,044,532.69-34,576,429.51-184,693,881.63
筹资活动现金流入小计533,012,809.3349,400,000159,700,000719,819,000
筹资活动现金流出小计480,020,125.74325,733,378.1158,812,898.77754,916,867.47
筹资活动产生的现金流量净额52,992,683.5623,666,621.9887,101.23-35,097,867.47
汇率变动对现金及现金等价物的影响103,516.6619,062.2419,062.24232,221.81
现金及现金等价物净增加额-58,778,444.23-119,816,687.37-51,553,821.84-58,857,731.8
期末现金及现金等价物余额191,411,578.34130,373,335.2198,636,200.73250,190,022.57
TOP↑